How should I manage a 25‑year‑old woman at 17 weeks + 2 days gestation who has mild gestational hypertension (blood pressure ~145/83 mm Hg) and an elevated alanine aminotransferase level of 77 U/L, with otherwise normal labs and no symptoms?

Management of Mild Gestational Hypertension with Elevated ALT at 17 Weeks

You should initiate antihypertensive therapy now, targeting blood pressure <140/90 mm Hg, while closely monitoring for progression to preeclampsia given the elevated ALT and early gestational age. 1

Immediate Classification and Risk Assessment

This patient meets criteria for gestational hypertension (BP ≥140/90 mm Hg after 20 weeks without proteinuria or organ dysfunction), though at 17+2 weeks she is technically just before the typical 20-week threshold. 1 The elevated ALT of 77 U/L (approximately 2× upper limit of normal) represents maternal organ dysfunction and raises concern for evolving preeclampsia, even without proteinuria. 1

Key concern: Gestational hypertension presenting before 34 weeks carries the highest risk of progression to preeclampsia—this patient is at particularly high risk given her early presentation at 17 weeks. 1

Treatment Threshold Decision

The most recent 2025 guidelines from the American College of Cardiology/American Heart Association and international societies now support a lower treatment threshold than traditional ACOG recommendations: 1

• International Society for the Study of Hypertension in Pregnancy (ISSHP) recommends: Initiate antihypertensive therapy at BP ≥140/90 mm Hg for gestational hypertension 1
• ACOG traditionally recommends: Treatment threshold of ≥160/110 mm Hg for gestational hypertension 1

However, the 2025 Circulation guidelines emphasize that treating BP consistently ≥140/90 mm Hg reduces severe maternal hypertension and complications. 1 Given this patient's elevated ALT suggesting early organ involvement, the lower threshold is appropriate. 1

Antihypertensive Medication Selection

Target diastolic BP of 85 mm Hg (systolic 110-140 mm Hg) to prevent severe hypertension while avoiding placental hypoperfusion. 1

First-line agents (choose one): 1

• Labetalol (oral)
• Methyldopa (oral)
• Nifedipine (oral, long-acting)

Avoid: ACE inhibitors and angiotensin receptor blockers (contraindicated in pregnancy). 2, 3

Reduce or cease medication if diastolic BP falls <80 mm Hg. 1

Monitoring Protocol for Preeclampsia Progression

The elevated ALT mandates heightened surveillance as this may represent early preeclampsia with hepatic involvement: 1

Laboratory monitoring (minimum twice weekly): 1

• Complete blood count (hemoglobin, platelets)
• Liver enzymes (AST, ALT, LDH)
• Renal function (creatinine, uric acid)
• Repeat proteinuria assessment (urine protein/creatinine ratio)

Clinical monitoring: 1

• BP checks at least twice weekly (consider home BP monitoring) 1
• Assess for symptoms: severe headache, visual changes, right upper quadrant pain, epigastric pain
• Check for hyperreflexia/clonus

Fetal surveillance: 1

• Baseline ultrasound for fetal biometry, amniotic fluid, umbilical artery Doppler
• Repeat every 2 weeks if normal; more frequently if growth restriction develops
• Given elevated uric acid association with worse fetal outcomes, detailed fetal growth assessment is warranted 1

Hospital Assessment Considerations

This patient should be assessed in hospital initially to confirm the diagnosis, exclude severe features, and establish baseline labs. 1 After confirming stability, outpatient management with close follow-up is acceptable if she is reliable for BP monitoring and symptom reporting. 1

Critical Red Flags Requiring Immediate Hospitalization

Admit immediately if any of the following develop: 1

• BP ≥160/110 mm Hg (requires urgent treatment within monitored setting)
• Severe headache or visual disturbances
• Right upper quadrant or epigastric pain
• Progressive thrombocytopenia (platelets declining)
• Worsening liver enzymes
• Rising creatinine
• Proteinuria development (would confirm preeclampsia diagnosis)
• Non-reassuring fetal status

Common Pitfalls to Avoid

Do not wait for severe hypertension (≥160/110 mm Hg) to initiate treatment in this case. While ACOG traditionally reserves treatment for severe range in gestational hypertension, the elevated ALT indicates this is not simple gestational hypertension—it suggests evolving preeclampsia with hepatic involvement. 1

Do not dismiss the elevated ALT as incidental. Liver enzyme elevation in the context of new-onset hypertension in pregnancy is a defining feature of preeclampsia, even without proteinuria (proteinuria is present in only ~75% of preeclampsia cases). 1

Confirm BP readings properly: Have BP rechecked by nursing staff using validated devices, as up to 25% of elevated office readings represent white-coat hypertension. 1 However, given two consistent elevated readings, this is likely true hypertension.

Prognosis and Delivery Planning

Gestational hypertension at this early gestation carries approximately 20-25% risk of progression to preeclampsia. 1 With the elevated ALT already present, progression risk is higher.

Delivery timing: If preeclampsia with severe features develops, delivery is indicated at 34 weeks or immediately if maternal/fetal compromise occurs. 1 If condition remains stable as gestational hypertension without severe features, delivery at 37 weeks is appropriate. 1